News – Page 644 – Endpoints News

A year into SPAC merger, Gemini restructures pipeline with 20% of staff, leadership on the chopping block

4 years ago

iOmx refuels with $75M+ on its search for immune checkpoint targets on tumor cells

4 years ago

GlaxoSmithKline abandoning iconic US HQ space in a shift inspired by the new normal

4 years ago

Vedanta brings home a win for lead microbiome program, passing a PhII test and clinching BARDA investment

4 years ago

Covid-19 roundup: Scientists pull pre-print with inflated incidence of myocarditis post mRNA vaccine; AstraZeneca ...

4 years ago

A month after a manufacturing hiccup led to a CRL, CorMedix CEO will retire

4 years ago

Feds accuse AstraZeneca of underpaying 318 female and Hispanic employees

4 years ago

Longtime NIH director Francis Collins resigns to make room for 'new vision'

4 years ago

New small molecule player with roots in David Liu's lab collects another $78M to fuel search for exosites

4 years ago

Gang of 7: Boehringer joins group of companies targeted over drug discount program

4 years ago

Estate of Henrietta Lacks sues Thermo Fisher over the improper sale of her immortal cells

4 years ago

AstraZeneca's Enhertu gets BTD for breast cancer; Centessa nabs $300M loan

4 years ago

Has Selecta found a way around gene therapy's delivery problem? Takeda puts down $1B-plus to find out

4 years ago

Teva temporarily padlocks a plant after FDA cites it for contamination

4 years ago

BioMarin recruits Vertex's translational chief to head up clinical trial ops

4 years ago

Enanta culls internal NASH work, betting on an out-licensing strategy in the disaster-strewn field

4 years ago

Canada's Xenon touts out-of-the-blue win for its daily epilepsy pill, sending investors into a frenzy

4 years ago

J&J signs on Xencor for a $100M licensing deal targeting CD20, looking to press its advantage in bispecifics

4 years ago

Thermo Fisher expands into Switzerland as part of CSL collaboration

4 years ago

J&J releases the first big data cut in the RSV vaccine race, setting bar for GlaxoSmithKline and Pfizer

4 years ago

Covid-19 roundup: J&J to apply for booster authorization this week as adcomms are set; BioNTech CEO Ugur Sahin ...

4 years ago

IPOs get back into gear with filings from LianBio and Xilio, and Cormorant's SPAC has a deal

4 years ago

Three generic firms shell out $447M more to settle federal price fixing allegations

4 years ago

Merck shakes hands with Acceleron; Finally, a pill for Covid-19; The past and future of contract research; and more

4 years ago

First page Previous page 641 642 643644645 646 647 Next page Last page